Home > What we do > Medicine & Healthcare > hMedicine > hMedicine Archive

Swedish Delegation Makes a Visit

Susanne Eberstein,  First Deputy Speaker of the Swedish parliament, the Riksdag, Swedish Ambassador to Israel Carl-Magnus Nesser, and Swedish MP’s Tommy Waidelich and Gustaf Hoffstedt visited Hadassah Medical Organization on February 11 as part of a fact-finding trip to the Middle East.

“It's a pleasure and so important to see how you treat patients from all backgrounds,” said Eberstein.

They were welcomed by Hadassah Hospital Medical Director Professor Yoram Weiss who provided a short  update on the research and advanced treatment at Hadassah's hospital, and accompanied by the Israel Foreign Ministry Head of the North European Desk Amir Maimon.

With 500 beds, 19 stories (five underground) and state-of-the-art technical equipment, the Tower is the most advanced medical facility in the Middle East.

DONATE

Join

Advocate

Lead

LEARN MORE

View all of our Impact Areas

The delegation visited the healing gardens of the Sarah Wetsman Davidson Tower, where they also heard of the preference of Jerusalem patients to have double rooms instead of the private rooms preferred in countries like Sweden or the United States as an example of multiculturalism in action at Hadassah Medical Organization. They saw the Chagall windows, with their potent symbols of justice and peace, created for the Hadassah synagogue by the late artist Marc Chagall. In the Pediatric Intensive Care Unit, Ms. Eberstein and her delegation visited a two-month old Palestinian patient from Nablus who is being cared for while preparing for cardiac surgery.

Date: 2/11/2014


More hMedicine Stories




Hadasit, Hadassah’s Technology Transfer Arm, Reviews 2012’s Accomplishments

When the Hadassah University Medical Center’s physicians suggest a solution to a medical problem which can lead to the development of a new medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its feasibility and supports the promotion of those viable ideas with innovation potential. Although 2012 has been “a year full of challenges for the life science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer, Hadasit still signed 125 agreements for clinical trials, all to be done at Hadassah. In addition, Hadasit signed 15 agreements for cooperation and commercialization of technologies that were developed at Hadassah. Click here to read the latest Newsletter from Hadasit >>

   |  Who We Are  |  What We Do  |  Where We Do It  |  Read About It  |  Join Now  |  Donate  |
  |  Login  |  Contact Us  |  Careers  |  Terms & Conditions  |  
Copyright ©2014 Hadassah is a registered trademark of Hadassah, the Women's Zionist Organization of America